Respi Immuno Dx™

Respi Immuno Dx™

Lung infection represents the most frequent infectious complication in immunocompromised patients. VolenteDx is proud to offer our best in industry Respi Immuno Dx™ diagnostic panel. Patients with immune system compromise will often suffer from complex infections because of their reduced ability to fight off infections. Often, the organisms within the lungs are mixed, and patients may complain of atypical symptoms which can be due to the presence of multidrug-resistant organisms. Infections in the lungs can seriously jeopardize the health of immunosuppressed patients. The number of patients infected with multidrug-resistant bacteria or opportunistic pathogens such as Mycobacteria, Pneumocystis, Candida, and Aspergillus is increasing as the numbers of immunosuppressed patients with HIV/AIDS, solid-organ transplant and hematopoietic transplantations, cancer and systemic illnesses increases. Fewer and fewer effective antibiotics are available; therefore, there is a tremendous need for better diagnostics. VolenteDx has developed a quick and accurate detection test for pathogens relevant to immunocompromised patients. The combination of Respi Immuno Dx™ and Antibiotic Resistance Dx™ gives physicians the best guidance on treatment regimens to avoid the development of further resistance and to maximize effectiveness. VolenteDx brings together valuable tools for the best in diagnostics for the immunocompromised patient, avoidance of adverse events and prevention of unnecessary antibiotic prescribing.